{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:42:47Z","timestamp":1783392167586,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010564","name":"Deutsches Zentrum f\u00fcr Lungenforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.biopha.2023.115959","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T22:52:00Z","timestamp":1701903120000},"page":"115959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Inhibition of SARS-CoV-2 infection and replication by Petasites hybridus CO2-extract (Ze 339)"],"prefix":"10.1016","volume":"170","author":[{"given":"Constanze A.","family":"Jakwerth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Grass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Erb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pichlmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Boonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7516-8789","authenticated-orcid":false,"given":"Veronika","family":"Butterweck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3203-8084","authenticated-orcid":false,"given":"Carsten B.","family":"Schmidt-Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2023.115959_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.31083\/j.fbl2704123","article-title":"Current update of phytotherapeutic agents in the treatment of COVID-19: in-silico based virtual screening approach for the development of antiviral drug","volume":"27","author":"Ramesh","year":"2022","journal-title":"Front Biosci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115959_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/computation10010007","article-title":"Virtual combinatorial library screening of quinadoline B derivatives against SARS-CoV-2 RNA-dependent RNA polymerase","volume":"10","author":"Brogi","year":"2022","journal-title":"Computation"},{"issue":"7","key":"10.1016\/j.biopha.2023.115959_bib3","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1021\/acs.jpclett.0c03119","article-title":"Kobophenol A inhibits binding of host ACE2 receptor with spike RBD domain of SARS-CoV-2, a lead compound for blocking COVID-19","volume":"12","author":"Gangadevi","year":"2021","journal-title":"J. Phys. Chem. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2023.115959_bib4","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1093\/cid\/ciac443","article-title":"Effectiveness of paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients","volume":"76","author":"Najjar-Debbiny","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2023.115959_bib5","unstructured":"C.-T.G. Panel, Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at \u3008https:\/\/www.covid19treatmentguidelines.nih.gov\/\u3009. Accessed September 09, 2023., (2023)."},{"issue":"11","key":"10.1016\/j.biopha.2023.115959_bib6","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/cid\/ciad066","article-title":"Guidance on the use of convalescent plasma to treat immunocompromised patients with coronavirus disease 2019","volume":"76","author":"Bloch","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"17","key":"10.1016\/j.biopha.2023.115959_bib7","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111608","article-title":"Attenuation of SARS-CoV-2 replication and associated inflammation by concomitant targeting of viral and host cap 2'-O-ribose methyltransferases","volume":"41","author":"Bergant","year":"2022","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.biopha.2023.115959_bib8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2023.115959_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41588-020-00759-x","article-title":"A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection","volume":"53","author":"Blume","year":"2021","journal-title":"Nat. Genet"},{"issue":"12","key":"10.1016\/j.biopha.2023.115959_bib10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41588-020-00731-9","article-title":"Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor","volume":"52","author":"Onabajo","year":"2020","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.biopha.2023.115959_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00109-022-02182-7","article-title":"Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B(2) receptor antagonism","volume":"100","author":"Jakwerth","year":"2022","journal-title":"J. Mol. Med."},{"issue":"8","key":"10.1016\/j.biopha.2023.115959_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9080659","article-title":"Flavonoids activation of the transcription factor Nrf2 as a hypothesis approach for the prevention and modulation of SARS-CoV-2 infection severity","volume":"9","author":"Mendonca","year":"2020","journal-title":"Antioxidants"},{"issue":"38","key":"10.1016\/j.biopha.2023.115959_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301518120","article-title":"Targeting spike glycans to inhibit SARS-CoV2 viral entry","volume":"120","author":"Guseman","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2023.115959_bib14","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154305","article-title":"ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion","volume":"23","author":"Jocher","year":"2022","journal-title":"EMBO Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.115959_bib15","doi-asserted-by":"crossref","first-page":"L493","DOI":"10.1152\/ajplung.00285.2022","article-title":"Mucociliary clearance augmenting drugs block SARS-CoV-2 replication in human airway epithelial cells","volume":"324","author":"Campos-Gomez","year":"2023","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"Suppl 4","key":"10.1016\/j.biopha.2023.115959_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1078\/1433-187X-00304","article-title":"A newly developed extract (Ze 339) from butterbur (Petasites hybridus L.) is clinically efficient in allergic rhinitis (hay fever)","volume":"10","author":"Brattstrom","year":"2003","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2023.115959_bib17","unstructured":"P.J. O\u017carowski M., Adamczak A., Phytochemical, pharmacological and clinical studies of Petasites hybridus 2013."},{"key":"10.1016\/j.biopha.2023.115959_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jchromb.2015.05.027","article-title":"UPLC TOF MS for sensitive quantification of naturally occurring pyrrolizidine alkaloids in Petasites hybridus extract (Ze 339)","volume":"997","author":"Schenk","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115959_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ph14030180","article-title":"Treatment of early allergic and late inflammatory symptoms of allergic rhinitis with petasites hybridus leaf extract (Ze 339): results of a noninterventional observational study in Switzerland","volume":"14","author":"Blosa","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.biopha.2023.115959_bib20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1567-5769(02)00046-2","article-title":"Anti-inflammatory activity of an extract of Petasites hybridus in allergic rhinitis","volume":"2","author":"Thomet","year":"2002","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115959_bib21","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1046\/j.1365-2222.2001.01158.x","article-title":"Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils","volume":"31","author":"Thomet","year":"2001","journal-title":"Clin. Exp. Allergy"},{"issue":"8","key":"10.1016\/j.biopha.2023.115959_bib22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0006-2952(01)00552-4","article-title":"Role of petasin in the potential anti-inflammatory activity of a plant extract of Petasites hybridus","volume":"61","author":"Thomet","year":"2001","journal-title":"Biochem Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115959_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/biof.1349","article-title":"Anti-inflammatory effects of the petasin phyto drug Ze339 are mediated by inhibition of the STAT pathway","volume":"43","author":"Steiert","year":"2017","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.biopha.2023.115959_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/v14010106","article-title":"The Petasites hybridus CO(2) Extract (Ze 339) Blocks SARS-CoV-2 Replication In Vitro","volume":"14","author":"Urda","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.115959_bib25","unstructured":"V. Koch, R. Rittinghausen, Composition containing pyrrolizidine-alkaloid-free Petasites, Max Zeller S\u00f6hne AG, USA, 2003."},{"key":"10.1016\/j.biopha.2023.115959_bib26","first-page":"1","article-title":"Method for producing medicinal plant extracts","author":"Steiner","year":"1999","journal-title":"Max Zeller Soehne AG"},{"issue":"7813","key":"10.1016\/j.biopha.2023.115959_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-020-2294-9","article-title":"Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform","volume":"582","author":"Thi Nhu Thao","year":"2020","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.biopha.2023.115959_bib28","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.biopha.2023.115959_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/bios12110929","article-title":"Genome-wide gene expression analysis reveals unique genes signatures of epithelial reorganization in primary airway epithelium induced by type-I, -II and -III interferons","volume":"12","author":"Erb","year":"2022","journal-title":"Biosensors"},{"issue":"7813","key":"10.1016\/j.biopha.2023.115959_bib30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-020-2294-9","article-title":"Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform","volume":"582","author":"Thi Nhu Thao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115959_bib31","doi-asserted-by":"crossref","unstructured":"A. Schafer, D.R. Martinez, J.J. Won, F.R. Moreira, A.J. Brown, K.L. Gully, R. Kalla, K. Chun, V. Du Pont, D. Babusis, J. Tang, E. Murakami, R. Subramanian, K.T. Barrett, B.J. Bleier, R. Bannister, J.Y. Feng, J.P. Bilello, T. Cihlar, R.L. Mackman, S.A. Montgomery, R.S. Baric, T.P. Sheahan, Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice, bioRxiv 2021.","DOI":"10.1101\/2021.09.13.460111"},{"key":"10.1016\/j.biopha.2023.115959_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2021.104986","article-title":"Extract matrix composition does not affect in vitro leukotriene inhibitory effects of the Petasites hybridus extract Ze 339","volume":"153","author":"Kodjadjiku","year":"2021","journal-title":"Fitoterapia"},{"issue":"7917","key":"10.1016\/j.biopha.2023.115959_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-022-04576-6","article-title":", Whole-genome sequencing reveals host factors underlying critical COVID-19","volume":"607","author":"Kousathanas","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2023.115959_bib34","first-page":"178","article-title":"Innate immune evasion strategies of SARS-CoV-2","volume":"21","author":"Minkoff","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115959_bib35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2101643","article-title":"Tofacitinib in patients hospitalized with covid-19 Pneumonia","volume":"385","author":"Guimaraes","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115959_bib36","article-title":"The role of IL-36 in infectious diseases: potential target for COVID-19?","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115959_bib37","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jaad.2020.06.1014","article-title":"The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway-inhibiting biologics: a meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic","volume":"83","author":"Syed","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.biopha.2023.115959_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1145840","article-title":"Serum IL-23, IL-10, and TNF-alpha predict in-hospital mortality in COVID-19 patients","volume":"14","author":"Smail","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115959_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5306\/wjco.v14.i8.311","article-title":"Readmission rates and outcomes in adults with and without COVID-19 following inpatient chemotherapy admission: a nationwide analysis","volume":"14","author":"Kanemo","year":"2023","journal-title":"World J. Clin. Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223017572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223017572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:36:07Z","timestamp":1773966967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223017572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":39,"alternative-id":["S0753332223017572"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115959","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of SARS-CoV-2 infection and replication by Petasites hybridus CO2-extract (Ze 339)","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115959"}}